Clinical Acceleration Has Outpaced Commercial Infrastructure

Propel Biosciences builds the commercialization systems that close that gap for cell and gene therapy and life sciences companies.

Take the Commercial Gravity Score

Nine questions. A few minutes.
A clear view of what to fix first.

Get My Score

Where scientific potential becomes commercial success

From founder-led sales to scale-up to a repeatable revenue engine, Propel builds the commercial foundation for every stage of growth. We combine strategic clarity with hands-on execution so your science reaches the right buyers and partners.

Ways To Work With Propel

Strategy

A clear commercialization plan built for your market, technology, and goals.

Learn more

Strategy + Execution

Strategy brought to life through targeted outreach, early pipeline development, message refinement, and partnership building.

Learn more

Fractional Commercial Leadership

CCO and CBO level leadership, sized to your needs, without a full-time hire.

Learn more

Fractional BD Support

Experienced life sciences business development, fractional and sized to where you are.

Learn more

Why Companies Choose Propel

Propel combines scientific fluency, commercial strategy, targeted execution, and fractional leadership into one integrated acceleration partner.

We bring:

  • A proven framework customized for every client
  • Hands-on execution, not just recommendations
  • Proprietary buyer & partner intelligence
  • Sales enablement & outreach support
  • Executive-level commercial leadership

We don’t hand you a plan. We help you build the commercial engine that drives results.

Propel Bio In Numbers

20+
Clients Served
25+
Years in Life Sciences Commercialization
$1B+
In Commercial Pipelines Built
24,000+
LinkedIn Followers
10,000+
Unique Contacts in the Proprietary CGT Database

What Our Clients Say

“Susan was able to quickly step into our team as a fractional commercial leader and help organize our sales and marketing processes, as well as support development of our commercial strategy as we prepared for a new product launch. Susan brought a wealth of knowledge and best practices into our organization.”
Brian Feth, CEO of Xcell Bio
Brian FethCEO, Xcell Bio
“Susan quickly proved to be an invaluable partner to our team, bringing both deep cell and gene therapy expertise and a thoughtful, practical approach to every challenge. With more than 15 years of experience in scientific and commercial leadership roles, she was able to rapidly understand our technology and contribute meaningfully across a variety of cross-functional discussions.”
Luděk Sojka, SCTbio
Luděk SojkaCEO, SCTbio
“Working with Susan to develop our sales playbook was an extremely valuable experience. She brought structure, clarity, and an outside perspective that helped us sharpen our messaging and align sales and marketing more effectively. The playbook has become a practical, go-to resource for our team.”
Patrick Myles, CEO of PathPresenter
Patrick MylesCEO, PathPresenter